PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Significantly reduced plasma glucose and lactate dehydrogenase levels in diabetic rats [PMID:35168075]
Mitigated diabetic neuropathy in rats, affecting parameters such as plasma glucose and motor nerve conduction velocity [PMID:34149415]
Ameliorated nephropathy in rats by inhibiting TGF-β1 and oxidative stress [PMID:32674108]
Demonstrated potent antibacterial activity against S. epidermidis, P. vulgaris, S. aureus, E. coli, P. aeruginosa, and S. typhi [PMID:22171288]
Evaluated for antifungal properties as a denture cleanser [PMID:28300045]
Used in a pilot study for the management of high serum levels of copper, zinc, and lead in workers [PMID:34690043]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 35168075 (2022) — Triphala churna ameliorates retinopathy in diabetic rats. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
- 2.PMID: 34149415 (2021) — Triphala Churna-A Traditional Formulation in Ayurveda Mitigates Diabetic Neuropathy in Rats. · Frontiers in pharmacology
- 3.PMID: 22171288 (2011) — Antibacterial activity of some Indian Ayurvedic preparations against enteric bacterial pathogens. · Journal of advanced pharmaceutical technology & research
- 4.PMID: 32674108 (2020) — Triphala Ameliorates Nephropathy via Inhibition of TGF-β1 and Oxidative Stress in Diabetic Rats. · Pharmacology
- 5.PMID: 28300045 (2017) — "Nature cures:" An alternative herbal formulation as a denture cleanser.